Data / New clinical trials / Lung Neoplasms
Lung Neoplasms trials: 741 new since Nov 2024
The full list. New Lung Neoplasms clinical trials: 741 rows for $37.05, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 35 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/lung-neoplasms, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
741 clinical studies in Lung Neoplasms were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 128 have an industry sponsor and 595 are recruiting or about to. The newest, NCT07926542, was posted on November 9, 2026: Dexmedetomidine as an add-on Sedative for Endobronchial Ultrasound (Centro Hospitalar de Lisboa Central).
The request: Every new Lung Neoplasms clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 741New trials
- 128Industry sponsored
- 595Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 741, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07926542 | Dexmedetomidine as an add-on Sedative for Endobronchial Ultrasound | Centro Hospitalar de Lisboa Central | Not applicable | Completed | Conscious Sedation, Lung Neoplasms, Lymphadenopathy (Mediastinal) | 40 | Portugal | clinicaltrials.gov |
| November 4, 2026 | NCT07915193 | Application of Generative Artificial Intelligence in Perioperative Personalized Rehabilitation for Older Adults With Lung Cancer | Peking University Cancer Hospital & Institute | Not applicable | Enrolling by invitation | Lung Neoplasms | 150 | China | clinicaltrials.gov |
| November 4, 2026 | NCT07914881 | A Study to Screen for Lung Cancer in High-risk Individuals Who Have Never Smoked Using Low-dose Computed Tomography (LDCT). | AstraZeneca | Observational | Not yet recruiting | Lung Cancer, Thoracic Tumors | 200 | clinicaltrials.gov | |
| November 3, 2026 | NCT07913256 | The Impact of Rheumatoid Arthritis Treatments on the Modulation of Extracellular Vesicles and Other Biomarkers Involved in the Development... | University Hospital, Limoges | Observational | Not yet recruiting | Rheumatoid Arthritis (RA), Lung Neoplasms | 136 | clinicaltrials.gov | |
| November 3, 2026 | NCT07912190 | ePRO in Advanced Lung Cancer: Emotional Distress, Symptom Burden, Brain Metastasis | Qian Chu | Observational | Recruiting | Lung Cancer, Brain Metastasis, Patient Reported Outcome | 200 | China | clinicaltrials.gov |
| November 2, 2026 | NCT07911267 | Development and Utilization of an Integrated Clinical Genomic Database | Samsung Medical Center | Observational | Recruiting | Gastric Cancer, Colorectal Cancer, Lung Cancer (NSCLC), Liver Cancer, Pancreatic Cancer | 118,750 | South Korea | clinicaltrials.gov |
| November 2, 2026 | NCT07910942 | A Phase 1 Trial of KAN-001 With Pembrolizumab, With or Without Chemotherapy, in Participants With PD-L1-Positive Non-Small Cell Lung Cancer | Kanvas Biosciences | Phase 1 | Not yet recruiting | Non-Small Cell Lung Cancer | 40 | Canada, United States | clinicaltrials.gov |
| November 2, 2026 | NCT07909343 | Patient Needs and Preferences for NSCL Cancer Treatment Monitoring | European Institute of Oncology | Observational | Recruiting | Lung Cancer (NSCLC) | 35 | Italy | clinicaltrials.gov |
| October 30, 2026 | NCT07906626 | Snakehead Fish Extract and Curcumin Co-Supplementation in Advanced Lung Cancer on Inflammation, Nutritional Status, and Quality of Life | Universitas Sumatera Utara | Not applicable | Completed | Lung Cancer (NSCLC) | 60 | Indonesia | clinicaltrials.gov |
| October 29, 2026 | NCT07903415 | A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors. | Pfizer | Phase 1 | Recruiting | Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma... | 280 | United States | clinicaltrials.gov |
| October 29, 2026 | NCT07902921 | STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic... | National Cancer Institute (NCI) | Phase 1/2 | Not yet recruiting | NSCLC, Non-Small Cell Lung Cancer, Lung Cancer, Prostate Cancer, Thymic Epithelial Tumors, TETs, Thymic Carcinomas... | 67 | United States | clinicaltrials.gov |
| October 27, 2026 | NCT07898241 | Using an Artificial Intelligence Software Tool (iSeg) During Radiation Treatment Planning for Patients With Lung Tumors | Northwestern University | Not applicable | Not yet recruiting | Lung Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Lung | 34 | United States | clinicaltrials.gov |
| October 27, 2026 | NCT07897734 | TNG462-C103: Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Vopimetostat in Combination With ERAS-0015 in PDAC and... | Tango Therapeutics, Inc. | Phase 1/2 | Not yet recruiting | PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC, RAS Mutation, MTAP Deletion, Lung Cancer, Pancreatic Cancer... | 188 | clinicaltrials.gov | |
| October 26, 2026 | NCT07895277 | Longitudinal AI-Assisted Management of Indeterminate Pulmonary Nodules | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Not applicable | Recruiting | Pulmonary Nodules, Lung Neoplasms | 6,000 | China | clinicaltrials.gov |
| October 26, 2026 | NCT07895147 | Clinical Application of Artificial Intelligence Methods in Diagnostic Imaging of Pulmonary Nodules | Shanghai East Hospital | Observational | Active not recruiting | Pulmonary Nodules, Lung Neoplasms, Lung Diseases | 10,000 | China | clinicaltrials.gov |
| October 26, 2026 | NCT07894458 | MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer | Peking University People's Hospital | Not applicable | Recruiting | Lung Neoplasms, Neoadjuvant Therapy, Immunotherapy, Minimal Residual Disease | 100 | China | clinicaltrials.gov |
| October 23, 2026 | NCT07892300 | Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung Cancer | Oliver Jonas | Early phase 1 | Not yet recruiting | Lung Cancer, Mesothelioma, Suspected Lung Cancer, Suspected Mesothelioma | 20 | clinicaltrials.gov | |
| October 22, 2026 | NCT07890636 | Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLC | Ruijin Hospital | Phase 2 | Not yet recruiting | Lung Neoplasm Malignant | 64 | China | clinicaltrials.gov |
| October 22, 2026 | NCT07890038 | The Clinical Application Value of CAIX-Targeted PET Hypoxia Imaging in Malignant Tumors | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Active not recruiting | Nasopharyngeal Cancers, Lung Cancer (NSCLC), Esophageal Cancer, Glioma | 50 | China | clinicaltrials.gov |
| October 22, 2026 | NCT07889297 | Pulsed Field Ablation for the Treatment of Malignant Lung Tumors | Shanghai Chest Hospital | Not applicable | Not yet recruiting | Non-Small Cell Lung Cancer, Pulmonary Metastases | 15 | China | clinicaltrials.gov |
| October 20, 2026 | NCT07884487 | Surgical Margin Assessment Using Intra-operative High-resolution PET/CT in Patients With Cancers Referred to Surgical Resection, an... | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Not applicable | Active not recruiting | Breast Cancer, Head and Neck Cancers, Lung Cancer, Sarcoma, Liver Metastases From Colorectal Cancer, Gastro Intestinal... | 250 | Belgium | clinicaltrials.gov |
| October 20, 2026 | NCT07882758 | Union-LC-MPE Cohort:A Multicenter Cohort Study on Diagnosis and Prognosis of Malignant Pleural Effusion in Lung Cance | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Not yet recruiting | Malignant Pleural Effusions (Mpe), Lung Cancer (Diagnosis) | 3,000 | China | clinicaltrials.gov |
| October 20, 2026 | NCT07882628 | Diagnostic Performance of an AI-Based Multi-Omics Model for Early Lung Cancer | Beijing Chao Yang Hospital | Observational | Not yet recruiting | Pulmonary Nodules, Early Detection of Cancer, Lung Neoplasms | 1,050 | China | clinicaltrials.gov |
| October 16, 2026 | NCT07878871 | Firmonertinib Plus Chemotherapy for Unresectable EGFR PACC-Mutant Stage III Lung Cancer: A Phase II Study | Hunan Province Tumor Hospital | Phase 2 | Not yet recruiting | Lung Adenocarcinoma, Stage III Lung Cancer, EGFR Positive Non-small Cell Lung Cancer | 27 | China | clinicaltrials.gov |
| October 14, 2026 | NCT07874464 | Prospective Phase II Study of Concurrent Radiotherapy Combined With Full-Course Immunotherapy or Consolidation Immunotherapy for Locally... | Sun Yat-sen University | Phase 2 | Not yet recruiting | Lung Cancer (NSCLC) | 256 | China | clinicaltrials.gov |
| October 13, 2026 | NCT07871656 | Lung Cancer Detection in Never Smokers Using Urine Volatile Organic Compound (VOCs) | Thomas Jefferson University | Observational | Recruiting | Lung Cancer | 87 | United States | clinicaltrials.gov |
| October 8, 2026 | NCT07864584 | Study Using a Drug-device Combination Product to Determine Safety, Tolerability and Antitumor Activity for Patients With Advanced... | Nob Hill Therapeutics, Inc. | Phase 1/2 | Not yet recruiting | NSCLC (Advanced Non-small Cell Lung Cancer) | 100 | United States | clinicaltrials.gov |
| October 7, 2026 | NCT07862816 | Robotic Bronchoscopy for Small Lung Nodules Without a Bronchus Sign | Intuitive Surgical | Observational | Not yet recruiting | Lung Cancer (Diagnosis) | 151 | South Korea | clinicaltrials.gov |
| October 6, 2026 | NCT07861282 | Telerehabilitation Exercise Program for Postoperative Recovery in Lung Cancer. | University of Seville | Not applicable | Recruiting | Lung Neoplasms, Thoracic Surgery Lung | 56 | Spain | clinicaltrials.gov |
| October 6, 2026 | NCT07860359 | Impact of Lung Cancer Screening With Chest Scans Combined With Coaching on Smoking Cessation in Heavy Smokers | Hôpital Fribourgeois | Not applicable | Not yet recruiting | Lung Cancer (Diagnosis), Smoking Cessation, Lung Neoplasm | 116 | Switzerland | clinicaltrials.gov |
| October 5, 2026 | NCT07858552 | Nodify Lung Testing for Pulmonary Nodules | Biodesix, Inc. | Observational | Not yet recruiting | Indeterminate Pulmonary Nodule | 1,000 | clinicaltrials.gov | |
| October 5, 2026 | NCT07858253 | CLEAR-Lung III: Circulating Tumor DNA-Guided Consolidation Chemotherapy and Immunotherapy | Anusha Chidharla, MD | Phase 2 | Not yet recruiting | Lung Cancer | 43 | clinicaltrials.gov | |
| October 5, 2026 | NCT07857694 | Thoracic Radiotherapy Plus EGFR-TKI for Stage III EGFR-mutant Lung Adenocarcinoma | Laibin People's Hospital | Observational | Completed | Lung Cancer Stage III, EGFR Activating Mutation | 202 | China | clinicaltrials.gov |
| October 5, 2026 | NCT07857616 | SI-B036-ST-101 in Advanced/Metastatic Solid Tumors | SystImmune Inc. | Phase 1 | Recruiting | Locally Advanced /Metastatic Solid Tumors, Locally Advanced / Metastatic Solid Tumors, Metastatic Solid Cancers, Non... | 424 | United States | clinicaltrials.gov |
| October 1, 2026 | NCT07853443 | Symptoms, Physical Function, and Recovery in Patients Receiving Lung Cancer Treatment Before Surgery | Aerospace Center Hospital | Observational | Not yet recruiting | Lung Cancer (Diagnosis), Patient-Reported Symptom Burden, Physical Function | 360 | clinicaltrials.gov | |
| October 1, 2026 | NCT07853157 | AI-Assisted 3D Reconstruction for Lung Resection Planning | S. Andrea Hospital | Observational | Not yet recruiting | Lung Cancer, Artifical Intelligence, Surgery for Primary Lung Cancer | 50 | Italy | clinicaltrials.gov |
| October 1, 2026 | NCT07852000 | Radiomics for Distinguishing Benign and Malignant Lung Nodules | Assiut University | Observational | Not yet recruiting | Solitary Pulmonary Nodule, Lung Neoplasms, Multiple Pulmonary Nodules | 255 | clinicaltrials.gov | |
| September 30, 2026 | NCT07849400 | Video-guided Versus Conventional Right-sided Double-lumen Tube Placement for Thoracoscopic Surgery | Diansan Su | Not applicable | Not yet recruiting | Right-sided Double-lumen Tube Positioning, Lung Isolation During Thoracoscopic Surgery, One-lung Ventilation, Lung... | 566 | China | clinicaltrials.gov |
| September 30, 2026 | NCT07848815 | Risk-Based Lung Cancer Detection in COPD Patients | Vejle Hospital | Not applicable | Recruiting | Lung Cancer (Diagnosis), COPD (Chronic Obstructive Pulmonary Disease) | 1,000 | Denmark | clinicaltrials.gov |
| September 29, 2026 | NCT07848243 | Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes | Peking University Cancer Hospital & Institute | Phase 2 | Recruiting | Lung Cancer (NSCLC), Cervical Squamous Cell Cancer, Melanoma (Skin Cancer), Breast Cancer, Gastrointestinal Cancers | 50 | China | clinicaltrials.gov |
| September 29, 2026 | NCT07847138 | The Effect of Music on Anxiety and Caregiver Burden in Family Caregivers of Patients With Lung Cancer | Izmir Bakircay University | Not applicable | Completed | Anxiety, Evidence-based Practice, Caregiver Burden, Nursing, Lung Cancer | 50 | Turkey (Türkiye) | clinicaltrials.gov |
| September 25, 2026 | NCT07841249 | Cardiorespiratory Fitness After Lobectomy Versus Sublobar Resection | Tongji Hospital | Observational | Recruiting | Lung Cancer (NSCLC) | 604 | China | clinicaltrials.gov |
| September 24, 2026 | NCT07839325 | MIND-WELL Intervention | University of Arizona | Not applicable | Not yet recruiting | Lung Cancer (Diagnosis), Caregiver, Stress | 80 | United States | clinicaltrials.gov |
| September 24, 2026 | NCT07838519 | Personalizing Veterans' Lung Cancer Screening and Diagnosis | VA Office of Research and Development | Not applicable | Enrolling by invitation | Lung Cancer Screening, Military Service-related Environmental and Occupational Exposures, Cancer Survivor, Family... | 1,400 | United States | clinicaltrials.gov |
| September 23, 2026 | NCT07835789 | Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung Cancer | NRG Oncology | Phase 2 | Not yet recruiting | Locally Recurrent Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 | 138 | clinicaltrials.gov | |
| September 22, 2026 | NCT07834268 | Feasibility of Multi-cancer Early Detection Test in Screening Population (NQMD-CS) | Fifth Affiliated Hospital of Guangzhou Medical University | Not applicable | Active not recruiting | Colorectal Cancer, Grastic Cancer, Esophageal Cancer, Lung Cancer, Liver Cancer | 1,250 | China | clinicaltrials.gov |
| September 22, 2026 | NCT07833085 | CAIX-targeted PET/CT in Solid Tumors | Zhongnan Hospital | Not applicable | Recruiting | Malignant Solid Tumors, Clear Cell Renal Cell Carcinoma, Lung Cancer (NSCLC), Breast Cancer | 100 | China | clinicaltrials.gov |
| September 21, 2026 | NCT07830095 | 5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for Pulmonary Malignancies | Shanghai Chest Hospital | Not applicable | Not yet recruiting | Lung Cancer | 15 | China | clinicaltrials.gov |
| September 21, 2026 | NCT07829744 | Perioperative Targeted Therapy in Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer With Rare Driver Mutations | Shanghai Zhongshan Hospital | Phase 2 | Not yet recruiting | Lung Cancer (NSCLC) | 190 | clinicaltrials.gov | |
| September 21, 2026 | NCT07829640 | AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Not applicable | Not yet recruiting | Lung Cancer | 15 | China | clinicaltrials.gov |
| September 18, 2026 | NCT07828938 | Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality... | Fondation Hôpital Saint-Joseph | Not applicable | Not yet recruiting | Lung Cancer (Non-Small Cell) | 2,400 | France | clinicaltrials.gov |
| September 18, 2026 | NCT07827885 | 20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC | Fondazione Policlinico Universitario Campus Bio-Medico | Not applicable | Completed | Non-Small Cell Lung Cancer | 80 | Italy | clinicaltrials.gov |
| September 18, 2026 | NCT07827183 | AI-Personalized Discharge Education for Patients After Lung Cancer Surgery | Xiamen University | Not applicable | Recruiting | Lung Cancer (Diagnosis) | 156 | China | clinicaltrials.gov |
| September 17, 2026 | NCT07824778 | Construction and Application Research of a Multidisciplinary Combined Exercise Management Program for Elderly Lung Cancer Patients After... | Sir Run Run Shaw Hospital | Not applicable | Completed | Lung Cancer (NSCLC) | 68 | China | clinicaltrials.gov |
| September 17, 2026 | NCT07824583 | A Study Evaluating a New Radiation Treatment Workflow (NGDS) | Varian, a Siemens Healthineers Company | Not applicable | Recruiting | Lung Cancer (Diagnosis), Liver Cancer, Adult, Pancreatic Cancer, Thoracic Cancers, Abdominal Cancer | 20 | United States | clinicaltrials.gov |
| September 17, 2026 | NCT07824544 | An App to Identify Radiation Pneumonitis - a Pre-Study in Healthy Volunteers | University Hospital Schleswig-Holstein | Not applicable | Not yet recruiting | Lung Cancer | 30 | Denmark | clinicaltrials.gov |
| September 16, 2026 | NCT07822126 | Accurate Planning and Guidance of Bronchoscopy for Lung Cancer Management | Penn State University | Observational | Not yet recruiting | Lung Cancer (Diagnosis) | 6 | United States | clinicaltrials.gov |
| September 14, 2026 | NCT07819318 | C-Raven LDCT: Lung Cancer Screening Intervention | Johns Hopkins University | Not applicable | Not yet recruiting | Lung Cancer Screening | 300 | clinicaltrials.gov | |
| September 14, 2026 | NCT07818304 | SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLC | The First People's Hospital of Lianyungang | Phase 2 | Not yet recruiting | Non Small Cell Lung Cancer, Lung Neoplasms | 61 | China | clinicaltrials.gov |
| September 14, 2026 | NCT07817329 | NUT Project: Nutritional Support in Thoracic Oncology | Casa di Cura Dott. Pederzoli | Observational | Recruiting | Oncologic Diseases, Lung Cancer (NSCLC) | 100 | Italy | clinicaltrials.gov |
| September 11, 2026 | NCT07816263 | Guaraná Supplementation for Cancer-Related Fatigue | Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo | Observational | Recruiting | Cancer-related Fatigue, Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Cervical Cancer, Quality of Life | 60 | Colombia | clinicaltrials.gov |
| September 11, 2026 | NCT07815951 | Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid Tumors | Yong He | Phase 1 | Not yet recruiting | Solid Tumors, Carcinoma, Ovarian Neoplasms, Endometrial Neoplasms Malignant, Testicular Neoplasms, Lung Neoplasms... | 8 | China | clinicaltrials.gov |
| September 11, 2026 | NCT07815483 | A Multicenter Cohort Study of AI-Based Methods for Pulmonary Nodule Diagnosis and Follow-up | Shanghai East Hospital | Observational | Not yet recruiting | Pulmonary Nodules, Lung Neoplasms, Artificial Intelligence (AI) | 16,880 | clinicaltrials.gov | |
| September 11, 2026 | NCT07814872 | A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment | Harvard Medical School (HMS and HSDM) | Observational | Not yet recruiting | Neoplasms (Cancer / Tumors), Colorectal Neoplasms, Lung Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Pancreatic... | 30,000 | United States | clinicaltrials.gov |
| September 10, 2026 | NCT07812207 | Right Ventricular Afterload Indices in Lung Surgery | University of Glasgow | Observational | Not yet recruiting | Lung Cancer (Suspected or Confirmed), Thoracoscopic Lobectomy, One Lung Ventillation (OLV) | 15 | clinicaltrials.gov | |
| September 9, 2026 | NCT07810049 | Synchronous Bilateral Talc Pleurodesis | European Institute of Oncology | Observational | Completed | Bilateral Pleural Effusion, Pleurodesis | 31 | Italy | clinicaltrials.gov |
| September 8, 2026 | NCT07808164 | ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort | Tam Anh Research Institute | Observational | Recruiting | HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer), Gastric Carcinoma, Breast Cancer, Lung Cancer, Endometrial... | 162 | Vietnam | clinicaltrials.gov |
| September 8, 2026 | NCT07807696 | Olive Oil Before Lung Cancer Surgery to Prevent Chylothorax | Fudan University | Not applicable | Recruiting | Lung Cancer, Chylothorax | 1,036 | China | clinicaltrials.gov |
| September 8, 2026 | NCT07806981 | 18G Ultrafine Cryoablation Needle for Coaxial Biopsy and Cryoablation of Pulmonary Nodules | Shanghai Chest Hospital | Not applicable | Not yet recruiting | Pulmonary Nodules | 30 | clinicaltrials.gov | |
| September 8, 2026 | NCT07806682 | The Effects of Low Intensity Endurance Exercise on Improving Mitochondrial Function, Cell Bioelectrical Impedance Phase Angle, Fatigue and... | Taipei Medical University | Not applicable | Recruiting | Lung Cancer (Diagnosis) | 150 | Taiwan | clinicaltrials.gov |
| September 4, 2026 | NCT07804017 | Exhaled Breath Electronic Nose for Multi-Disease Risk Prescreening | The First Affiliated Hospital of Guangzhou Medical University | Observational | Not yet recruiting | Lung Cancer, Pulmonary Nodule, Chronic Respiratory Disease, Metabolic Disease, Endocrine Disease | 20,000 | clinicaltrials.gov | |
| September 3, 2026 | NCT07802847 | Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients. | Gustave Roussy, Cancer Campus, Grand Paris | Phase 4 | Not yet recruiting | Elderly, Breast Cancer, Lung Cancer, Prostate Cancer, Colon Cancer, Kidney Cancer, Sarcoma | 794 | France | clinicaltrials.gov |
| September 3, 2026 | NCT07802834 | Adjuvant ctDNA-Adapted Treatment With Zipalertinib in Early-Stage Atypical EGFR-Mutant NSCLC | Stanford University | Phase 2 | Not yet recruiting | EGFR, Lung Cancer (NSCLC), Non Small Cell Lung Cancer | 42 | clinicaltrials.gov | |
| September 2, 2026 | NCT07799974 | Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Association in Patients With Inoperable Lung Cancer: a... | University Hospital, Ghent | Observational | Recruiting | Lung Cancer (Locally Advanced or Metastatic) | 50 | Belgium | clinicaltrials.gov |
| September 2, 2026 | NCT07799194 | Percutaneous Pulsed Electric Field Ablation for Early-Stage NSCLC and Lung Oligometastases: A Safety and Efficacy Study | Energenx Medical LTD. | Not applicable | Not yet recruiting | Lung Cancer (NSCLC) | 10 | China | clinicaltrials.gov |
| September 2, 2026 | NCT07799038 | A Multicenter Prospective Study Evaluating the Diagnostic Performance of Femtosecond Laser Label-Free Imaging Combined With Artificial... | Shanghai Zhongshan Hospital | Observational | Not yet recruiting | Lung Cancer (Diagnosis) | 333 | clinicaltrials.gov | |
| September 1, 2026 | NCT07798362 | Iriscope for the Diagnosis of Peripheral Pulmonary Lesions: a Multicentre Randomised Controlled Trial | Erasme University Hospital | Not applicable | Not yet recruiting | Lung Nodule, Solitary, Lung Nodule, Lung Cancer (Diagnosis) | 140 | clinicaltrials.gov | |
| September 1, 2026 | NCT07796451 | Low-Frequency rTMS for Sleep After Thoracoscopic Lung Resection | The First Affiliated Hospital of Guangzhou Medical University | Not applicable | Not yet recruiting | Sleep Wake Disorders, Lung Neoplasms | 220 | clinicaltrials.gov | |
| August 31, 2026 | NCT07795580 | The Effects of Low-Intensity Endurance Exercise on Improving Fatigue, Sleep, Quality of Life, Mitochondrial Function, Cellular... | Taipei Medical University | Not applicable | Recruiting | Lung Cancer (Diagnosis) | 450 | Taiwan | clinicaltrials.gov |
| August 31, 2026 | NCT07795411 | Prospective Multiomic Analysis in Small-Cell Lung Cancer | Ohio State University Comprehensive Cancer Center | Observational | Recruiting | Small Cell Cancer Of The Lung, Small Cell Lung Cancer ( SCLC ), Lung Cancer, Small-Cell Lung Cancer (SCLC) | 30 | United States | clinicaltrials.gov |
| August 31, 2026 | NCT07794449 | A Multicenter, Prospective Study on the Diagnostic Efficacy of Femtosecond Laser Label-Free Imaging Combined With Artificial... | Shanghai Zhongshan Hospital | Observational | Not yet recruiting | Lung Cancer (Diagnosis) | 335 | clinicaltrials.gov | |
| August 28, 2026 | NCT07792824 | Witness Project Lung | Hackensack Meridian Health | Not applicable | Not yet recruiting | Lung Cancer | 400 | United States | clinicaltrials.gov |
| August 27, 2026 | NCT07791147 | Family-centred Pulmonary Rehabilitation to Empower Carers | Aveiro University | Not applicable | Not yet recruiting | Pulmonary Disease, Chronic Obstructive, Lung Diseases, Interstitial, Asthma, Lung Neoplasms, Bronchiectasis | 120 | Portugal | clinicaltrials.gov |
| August 27, 2026 | NCT07790406 | Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer | European Institute of Oncology | Observational | Recruiting | Lung Cancer (NSCLC) | 50 | Italy | clinicaltrials.gov |
| August 27, 2026 | NCT07789912 | BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies | University of Miami | Not applicable | Recruiting | Leptomeningeal Metastasis, Breast Cancer, Lung Cancer (NSCLC) | 40 | United States | clinicaltrials.gov |
| August 26, 2026 | NCT07788729 | Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons | University of Regensburg | Not applicable | Recruiting | Cancer, Lung Cancer, Colorectal Cancer, Hematological Cancer, Malignant Melanoma | 384 | Germany | clinicaltrials.gov |
| August 26, 2026 | NCT07786909 | ERICA-02 Study : Impact of Physical Exercise on the Tumor Immune Microenvironment in Patients Treated With Neoadjuvant Chemoimmunotherapy... | Centre Leon Berard | Not applicable | Recruiting | Lung Neoplasms, Non Small Cell Lung Cancer | 40 | France | clinicaltrials.gov |
| August 25, 2026 | NCT07785791 | ERAS Compliance and Nutritional Outcomes After Lung Cancer Surgery | Bursa City Hospital | Observational | Completed | Lung Cancer | 120 | Turkey (Türkiye) | clinicaltrials.gov |
| August 25, 2026 | NCT07783971 | Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance | 958th Army Hospital of the Chinese People's Liberation Army | Observational | Recruiting | Fungal Diseases, Lung Cancer (NSCLC), Microbioata | 10 | China | clinicaltrials.gov |
| August 24, 2026 | NCT07782359 | Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib | University of Chicago | Phase 1 | Recruiting | Lung Cancer | 30 | United States | clinicaltrials.gov |
| August 24, 2026 | NCT07782164 | Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) | Amsterdam UMC, location VUmc | Observational | Recruiting | Colorectal Carcinoma, Renal Cancer, Bladder Cancer, Cervical Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer... | 27 | Netherlands | clinicaltrials.gov |
| August 24, 2026 | NCT07781852 | Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer | Lumina Pharmaceuticals Inc | Early phase 1 | Not yet recruiting | Bladder Cancer, Glioma, Glioblastoma (GBM), Breast Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC)... | 40 | United States | clinicaltrials.gov |
| August 20, 2026 | NCT07777822 | Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous... | Revolution Medicines, Inc. | Phase 3 | Recruiting | NSCLC, Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer NSCLC, Non-Squamous Non Small Cell Lung Cancer, Lung... | 430 | United States | clinicaltrials.gov |
| August 20, 2026 | NCT07777614 | OPTIMISE Lung SABR | Cancer Trials Ireland | Phase 2 | Recruiting | Non Small Cell Lung Cancer | 208 | Ireland | clinicaltrials.gov |
| August 20, 2026 | NCT07776353 | Understanding New Cachexia Subtypes Through Observational Epidemiological Research | Kaiser Permanente | Observational | Recruiting | Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Pancreatic Adenocarcinoma, Stage IV... | 800 | United States | clinicaltrials.gov |
| August 20, 2026 | NCT07775820 | PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer | Nanfang Hospital, Southern Medical University | Observational | Recruiting | Lung Cancer, Rechallenge, Checkpoint Inhibitor Pneumonitis | 150 | China | clinicaltrials.gov |
| August 19, 2026 | NCT07772895 | Pemefolacianine for IMI of Lung Cancer | Sunil Singhal | Phase 1 | Recruiting | Lung Cancer (Locally Advanced or Metastatic) | 12 | United States | clinicaltrials.gov |
| August 19, 2026 | NCT07772804 | Effect of Mechanical Power-based Lung-protective Ventilation During One-lung Ventilation | Samsung Medical Center | Not applicable | Not yet recruiting | Lung Cancer (Diagnosis), Pulmonary Complications in Surgical Patients | 164 | South Korea | clinicaltrials.gov |
| August 17, 2026 | NCT07768124 | Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer | Xiu Huang | Not applicable | Recruiting | Lung Cancer (Diagnosis)Chemotherapy-Induced Nausea and Vomiting | 60 | China | clinicaltrials.gov |
| August 17, 2026 | NCT07768046 | Multiparametric Lung MRI With Diffusion-Weighted Imaging in Lung-RADS 4 Lesion Characterization | University of Florida | Observational | Not yet recruiting | Solitary Pulmonary Nodule, Multiple Pulmonary Nodules, Lung Neoplasms, Lung Cancer Screening | 30 | United States | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| The First Affiliated Hospital of Guangzhou Medical University | 17 | September 4, 2026 |
| Shanghai Chest Hospital | 14 | October 22, 2026 |
| AstraZeneca | 12 | November 4, 2026 |
| Shanghai Pulmonary Hospital, Shanghai, China | 11 | May 19, 2026 |
| Pfizer | 9 | October 29, 2026 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 9 | October 26, 2026 |
| Peking University People's Hospital | 8 | October 26, 2026 |
| National Cancer Institute (NCI) | 7 | October 29, 2026 |
| Massachusetts General Hospital | 7 | July 27, 2026 |
| Peking University Cancer Hospital & Institute | 6 | November 4, 2026 |
| European Institute of Oncology | 6 | November 2, 2026 |
| National Taiwan University Hospital | 6 | July 31, 2026 |
| Roswell Park Cancer Institute | 6 | July 22, 2026 |
| Sun Yat-sen University | 5 | October 14, 2026 |
| University Hospital Schleswig-Holstein | 5 | September 17, 2026 |
| M.D. Anderson Cancer Center | 5 | July 22, 2026 |
| Hacettepe University | 5 | June 12, 2026 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 5 | May 19, 2026 |
| Guangdong Provincial People's Hospital | 5 | March 16, 2026 |
| Merck Sharp & Dohme LLC | 5 | December 16, 2025 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 273 | November 9, 2026 |
| Observational | 245 | November 4, 2026 |
| Phase 2 | 104 | October 22, 2026 |
| Phase 1 | 48 | November 2, 2026 |
| Phase 1/2 | 27 | October 29, 2026 |
| Phase 3 | 23 | August 20, 2026 |
| Early phase 1 | 9 | October 23, 2026 |
| Phase 4 | 7 | September 3, 2026 |
| Phase 2/3 | 5 | October 8, 2025 |
By country
| Country | New trials | Latest |
|---|---|---|
| China | 227 | November 4, 2026 |
| United States | 195 | November 2, 2026 |
| France | 54 | September 18, 2026 |
| Italy | 53 | November 2, 2026 |
| Spain | 46 | October 6, 2026 |
| Turkey (Türkiye) | 38 | September 29, 2026 |
| South Korea | 32 | November 2, 2026 |
| United Kingdom | 32 | August 12, 2026 |
| Germany | 29 | August 26, 2026 |
| Taiwan | 27 | September 8, 2026 |
| Canada | 26 | November 2, 2026 |
| Australia | 26 | June 4, 2026 |
| Denmark | 23 | September 30, 2026 |
| Greece | 20 | June 4, 2026 |
| Poland | 20 | June 4, 2026 |
| Japan | 19 | May 22, 2026 |
| Belgium | 18 | October 20, 2026 |
| Netherlands | 18 | August 24, 2026 |
| Hong Kong | 18 | July 23, 2026 |
| Switzerland | 15 | October 6, 2026 |
| Brazil | 15 | June 1, 2026 |
| Hungary | 13 | August 3, 2026 |
| Israel | 12 | June 9, 2026 |
| Romania | 10 | December 16, 2025 |
| Argentina | 10 | October 30, 2025 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.